PDB53 Cost-Effectiveness of Saxagliptin (Onglyza®) in Type 2 Diabetes in South Africa
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.974
https://www.valueinhealthjournal.com/article/S1098-3015(12)01039-X/fulltext
Title :
PDB53 Cost-Effectiveness of Saxagliptin (Onglyza®) in Type 2 Diabetes in South Africa
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01039-X&doi=10.1016/j.jval.2012.03.974
First page :
A180
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
475